Portland, OR, United States of America

Lei G Wang

This inventor holds 3 USPTO granted patents and 12 published patent applications and 1 EPO patent. Top assignee: Oregon Health & Science University. Active years: 2022-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lei G Wang: Innovator in Nerve Imaging Technologies

Introduction

Lei G Wang is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of nerve imaging through his innovative patents. With a total of 3 patents, Wang's work focuses on developing advanced compounds for medical applications.

Latest Patents

Wang's latest patents include groundbreaking inventions such as oxazine-based fluorophore compounds for nerve-specific imaging. This invention concerns novel oxazine-based fluorophore compounds that are useful in in vivo nerve imaging, as well as compositions comprising them and methods for their use. Another notable patent is for near-infrared nerve-sparing benzo[c]phenoxazine fluorophores. This patent provides near-infrared nerve-sparing fluorescent compounds, compositions comprising them, and methods of their use in medical procedures.

Career Highlights

Wang is affiliated with Oregon Health & Science University, where he continues to advance research in nerve imaging technologies. His work has garnered attention for its potential to improve medical procedures and patient outcomes.

Collaborations

Wang collaborates with talented individuals such as Summer L Gibbs and Connor W Barth, contributing to a dynamic research environment.

Conclusion

Lei G Wang's innovative contributions to nerve imaging technologies highlight his role as a leading inventor in the medical field. His patents reflect a commitment to advancing healthcare through scientific discovery.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…